Showing results (31-40 of 42) with videos related to
Sort By:
Pageof 5
Annals of Ophthalmology (Skokie, Ill.)|December 9, 2010
Comparison of vitreous and plasma levels of vascular endothelial growth factor, interleukin-6 and hepatocyte growth factor in diabetic and non-diabetic retinal detachment casesNilufer Kocak, Inci Alacacioglu, Suleyman Kaynak, et al.Thrombosis Research|September 3, 2004
Plasma levels of thrombin activatable fibrinolysis inhibitor in normal and preeclamptic pregnant womenInci Alacacioğlu, Mehmet Ali Ozcan, Ahmet Alacacioğlu, et al.Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|October 30, 2018
A Comparison of Fresenius Com.Tec Cell and Spectra Optia Cell Separators for Autologous and Allogeneic Stem Cell Collections: Single Center ExperienceSerife Solmaz, Selda Kahraman, Omur Gokmen Sevindik, et al.Journal of Laboratory Physicians|December 1, 2018
Is the platelet-to-lymphocyte ratio a new prognostic marker in multiple myeloma?Serife Solmaz, Ozcan Uzun, Celal Acar, et al.Leukemia & Lymphoma|February 12, 2015
Hypoalbuminemia is a surrogate biomarker of poor prognosis in myelodysplastic syndrome even when adjusting for comorbiditiesOmur Gokmen Sevindik, Zeynep Guc, Selda Kahraman, et al.Clinical Lymphoma, Myeloma & Leukemia|March 21, 2015
IPSET-Thrombosis Better Identifies Thrombosis-Free Survival: A Turkish CohortOmur Gokmen Sevindik, Sinan Mersin, Abdullah Katgi, et al.Clinical Transplantation|July 28, 2018
Can Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, and Platelet-to-Lymphocyte Ratio at Day +100 be used as a prognostic marker in Multiple Myeloma patients with autologous transplantation?Serife Solmaz Medeni, Celal Acar, Aybuke Olgun, et al.Future Oncology (London, England)|June 9, 2023
Unmet clinical needs and challenges in the management of acute leukemia in Turkey: a modified Delphi studyMutlu Arat, Inci Alacacioglu, Ali Zahit Bolaman, et al.International Journal of Hematologic Oncology|June 6, 2022
The effect of comorbidities on the choice of tyrosine kinase inhibitors in patients with chronic myeloid leukemiaGuray Saydam, Ridvan Ali, Ahmet Muzaffer Demir, et al.American Journal of Blood Research|August 30, 2016
Pesg PNH diagnosis, follow-up and treatment guidelinesFahri Sahin, Olga Meltem Akay, Mesut Ayer, et al.Pageof 5